nodes	percent_of_prediction	percent_of_DWPC	metapath
Adinazolam—GABRP—uterine cervix—ovarian cancer	0.0332	0.0521	CbGeAlD
Adinazolam—GABRE—myometrium—ovarian cancer	0.0325	0.0511	CbGeAlD
Adinazolam—GABRP—decidua—ovarian cancer	0.0316	0.0496	CbGeAlD
Adinazolam—GABRP—endometrium—ovarian cancer	0.03	0.0471	CbGeAlD
Adinazolam—GABRG3—testis—ovarian cancer	0.029	0.0455	CbGeAlD
Adinazolam—GABRP—uterus—ovarian cancer	0.0276	0.0434	CbGeAlD
Adinazolam—GABRR1—testis—ovarian cancer	0.0276	0.0433	CbGeAlD
Adinazolam—GABRE—uterine cervix—ovarian cancer	0.0253	0.0397	CbGeAlD
Adinazolam—GABRB1—vagina—ovarian cancer	0.0251	0.0394	CbGeAlD
Adinazolam—GABRP—female reproductive system—ovarian cancer	0.0249	0.039	CbGeAlD
Adinazolam—GABRE—decidua—ovarian cancer	0.0241	0.0379	CbGeAlD
Adinazolam—GABRD—testis—ovarian cancer	0.024	0.0376	CbGeAlD
Adinazolam—GABRE—endometrium—ovarian cancer	0.0229	0.0359	CbGeAlD
Adinazolam—GABRP—vagina—ovarian cancer	0.0225	0.0353	CbGeAlD
Adinazolam—GABRA5—testis—ovarian cancer	0.0223	0.0349	CbGeAlD
Adinazolam—GABRR2—lymph node—ovarian cancer	0.0208	0.0326	CbGeAlD
Adinazolam—GABRA3—testis—ovarian cancer	0.0207	0.0325	CbGeAlD
Adinazolam—GABRE—female reproductive system—ovarian cancer	0.019	0.0298	CbGeAlD
Adinazolam—GABRB3—gonad—ovarian cancer	0.018	0.0283	CbGeAlD
Adinazolam—GABRA2—vagina—ovarian cancer	0.0173	0.0272	CbGeAlD
Adinazolam—GABRE—female gonad—ovarian cancer	0.0173	0.0271	CbGeAlD
Adinazolam—GABRE—vagina—ovarian cancer	0.0172	0.0269	CbGeAlD
Adinazolam—GABRB2—testis—ovarian cancer	0.0169	0.0265	CbGeAlD
Adinazolam—GABRB3—female reproductive system—ovarian cancer	0.0161	0.0252	CbGeAlD
Adinazolam—GABRE—testis—ovarian cancer	0.0153	0.024	CbGeAlD
Adinazolam—GABRB3—testis—ovarian cancer	0.013	0.0204	CbGeAlD
Adinazolam—CYP2C19—vagina—ovarian cancer	0.0126	0.0198	CbGeAlD
Adinazolam—GABRA2—lymph node—ovarian cancer	0.0112	0.0176	CbGeAlD
Adinazolam—GABRE—lymph node—ovarian cancer	0.0111	0.0174	CbGeAlD
Adinazolam—CYP3A4—female reproductive system—ovarian cancer	0.00823	0.0129	CbGeAlD
Adinazolam—Ketazolam—ABCB1—ovarian cancer	0.00641	0.192	CrCbGaD
Adinazolam—Clobazam—ABCB1—ovarian cancer	0.00453	0.136	CrCbGaD
Adinazolam—Nitrazepam—ABCB1—ovarian cancer	0.00375	0.112	CrCbGaD
Adinazolam—Clomipramine—ABCB1—ovarian cancer	0.00358	0.107	CrCbGaD
Adinazolam—Chlorprothixene—ABCB1—ovarian cancer	0.00357	0.107	CrCbGaD
Adinazolam—Flurazepam—ABCB1—ovarian cancer	0.00333	0.0998	CrCbGaD
Adinazolam—Midazolam—ABCB1—ovarian cancer	0.00309	0.0925	CrCbGaD
Adinazolam—Diazepam—ABCB1—ovarian cancer	0.00265	0.0793	CrCbGaD
Adinazolam—Chlorpromazine—ABCB1—ovarian cancer	0.00246	0.0736	CrCbGaD
Adinazolam—GABRA6—Neuronal System—NSF—ovarian cancer	0.00222	0.00673	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—NSF—ovarian cancer	0.00219	0.00665	CbGpPWpGaD
Adinazolam—GABRA1—Ion channel transport—ATP7B—ovarian cancer	0.00214	0.00651	CbGpPWpGaD
Adinazolam—CYP2C19—Melatonin metabolism and effects—CYP1B1—ovarian cancer	0.00213	0.00647	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—NSF—ovarian cancer	0.00209	0.00635	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—NSF—ovarian cancer	0.002	0.00608	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—NSF—ovarian cancer	0.00195	0.00591	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—NSF—ovarian cancer	0.00191	0.0058	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—NSF—ovarian cancer	0.00188	0.0057	CbGpPWpGaD
Adinazolam—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	0.00188	0.0057	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—NSF—ovarian cancer	0.00187	0.00566	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—NSF—ovarian cancer	0.00183	0.00556	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—IKBKG—ovarian cancer	0.00168	0.00511	CbGpPWpGaD
Adinazolam—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.00166	0.00504	CbGpPWpGaD
Adinazolam—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.00162	0.00493	CbGpPWpGaD
Adinazolam—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.00162	0.00491	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—NSF—ovarian cancer	0.0016	0.00486	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.00147	0.00447	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.00141	0.00429	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.00141	0.00427	CbGpPWpGaD
Adinazolam—CYP2C19—Arachidonic acid metabolism—CYP1B1—ovarian cancer	0.00138	0.00419	CbGpPWpGaD
Adinazolam—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	0.00136	0.00414	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.00135	0.00409	CbGpPWpGaD
Adinazolam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.00119	0.00362	CbGpPWpGaD
Adinazolam—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.00118	0.00357	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.00116	0.00351	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.00114	0.00346	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.00112	0.00339	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.00111	0.00337	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.00109	0.00332	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.00108	0.00327	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.00106	0.00323	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.00106	0.00323	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.00103	0.00314	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.00102	0.0031	CbGpPWpGaD
Adinazolam—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000976	0.00296	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000974	0.00296	CbGpPWpGaD
Adinazolam—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000966	0.00293	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000946	0.00287	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000934	0.00284	CbGpPWpGaD
Adinazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000929	0.00282	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000929	0.00282	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000913	0.00277	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000907	0.00275	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000907	0.00275	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000891	0.0027	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000891	0.0027	CbGpPWpGaD
Adinazolam—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000886	0.00269	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000877	0.00266	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000875	0.00266	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.00087	0.00264	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000864	0.00262	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000854	0.00259	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000817	0.00248	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000807	0.00245	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—APC—ovarian cancer	0.000796	0.00242	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000779	0.00236	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000746	0.00227	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000745	0.00226	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000738	0.00224	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000719	0.00218	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000717	0.00218	CbGpPWpGaD
Adinazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000716	0.00218	CbGpPWpGaD
Adinazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000712	0.00216	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000711	0.00216	CbGpPWpGaD
Adinazolam—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000707	0.00215	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000704	0.00214	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000692	0.0021	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000687	0.00209	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000686	0.00208	CbGpPWpGaD
Adinazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000679	0.00206	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000675	0.00205	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—MTOR—ovarian cancer	0.00061	0.00185	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.00059	0.00179	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000585	0.00178	CbGpPWpGaD
Adinazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000581	0.00176	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000576	0.00175	CbGpPWpGaD
Adinazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000571	0.00173	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000568	0.00172	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000565	0.00172	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—CASP3—ovarian cancer	0.000561	0.0017	CbGpPWpGaD
Adinazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000559	0.0017	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000557	0.00169	CbGpPWpGaD
Adinazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000551	0.00167	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000545	0.00166	CbGpPWpGaD
Adinazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000545	0.00165	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000542	0.00164	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—CTNNB1—ovarian cancer	0.000541	0.00164	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000538	0.00163	CbGpPWpGaD
Adinazolam—GABRR1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000535	0.00162	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000527	0.0016	CbGpPWpGaD
Adinazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000521	0.00158	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.00052	0.00158	CbGpPWpGaD
Adinazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000514	0.00156	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	0.000513	0.00156	CbGpPWpGaD
Adinazolam—GABRR2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.00051	0.00155	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000506	0.00154	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000492	0.0015	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000478	0.00145	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000476	0.00144	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000472	0.00143	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—STAT3—ovarian cancer	0.000471	0.00143	CbGpPWpGaD
Adinazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000471	0.00143	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.00047	0.00143	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000462	0.0014	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000462	0.0014	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000459	0.00139	CbGpPWpGaD
Adinazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000457	0.00139	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000454	0.00138	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000452	0.00137	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.00045	0.00137	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—MAPK3—ovarian cancer	0.00045	0.00137	CbGpPWpGaD
Adinazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000449	0.00136	CbGpPWpGaD
Adinazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000449	0.00136	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000446	0.00135	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000446	0.00135	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000443	0.00135	CbGpPWpGaD
Adinazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000442	0.00134	CbGpPWpGaD
Adinazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000441	0.00134	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000439	0.00133	CbGpPWpGaD
Adinazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000438	0.00133	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000435	0.00132	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000435	0.00132	CbGpPWpGaD
Adinazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.00043	0.00131	CbGpPWpGaD
Adinazolam—GABRR1—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000429	0.0013	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—MAPK1—ovarian cancer	0.000428	0.0013	CbGpPWpGaD
Adinazolam—GABRG3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.00042	0.00128	CbGpPWpGaD
Adinazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000418	0.00127	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000416	0.00126	CbGpPWpGaD
Adinazolam—GABRB1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000414	0.00126	CbGpPWpGaD
Adinazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000413	0.00125	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000411	0.00125	CbGpPWpGaD
Adinazolam—GABRR1—Neuronal System—MAPK1—ovarian cancer	0.00041	0.00124	CbGpPWpGaD
Adinazolam—GABRR2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.00041	0.00124	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000396	0.0012	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000394	0.0012	CbGpPWpGaD
Adinazolam—GABRA6—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000392	0.00119	CbGpPWpGaD
Adinazolam—GABRR2—Neuronal System—MAPK1—ovarian cancer	0.000391	0.00119	CbGpPWpGaD
Adinazolam—GABRA4—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000387	0.00117	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000383	0.00116	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.00038	0.00115	CbGpPWpGaD
Adinazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000378	0.00115	CbGpPWpGaD
Adinazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000376	0.00114	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000376	0.00114	CbGpPWpGaD
Adinazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000367	0.00111	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000365	0.00111	CbGpPWpGaD
Adinazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.00036	0.00109	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000358	0.00109	CbGpPWpGaD
Adinazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000354	0.00108	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000354	0.00107	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000352	0.00107	CbGpPWpGaD
Adinazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000352	0.00107	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.00035	0.00106	CbGpPWpGaD
Adinazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000345	0.00105	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—HRAS—ovarian cancer	0.000344	0.00104	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000344	0.00104	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000343	0.00104	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000337	0.00102	CbGpPWpGaD
Adinazolam—GABRG3—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000337	0.00102	CbGpPWpGaD
Adinazolam—GABRB1—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000332	0.00101	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000332	0.00101	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000329	0.001	CbGpPWpGaD
Adinazolam—GABRR1—Neuronal System—HRAS—ovarian cancer	0.000329	0.000999	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000324	0.000982	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—MAPK1—ovarian cancer	0.000322	0.000978	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—MAPK1—ovarian cancer	0.000317	0.000963	CbGpPWpGaD
Adinazolam—GABRA6—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000314	0.000955	CbGpPWpGaD
Adinazolam—GABRR2—Neuronal System—HRAS—ovarian cancer	0.000314	0.000953	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—NME2—ovarian cancer	0.000313	0.00095	CbGpPWpGaD
Adinazolam—GABRA4—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.00031	0.000943	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.000309	0.000937	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000304	0.000924	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—AKT1—ovarian cancer	0.000304	0.000922	CbGpPWpGaD
Adinazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000302	0.000917	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.0003	0.000912	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—MAPK1—ovarian cancer	0.0003	0.000911	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—MAPK1—ovarian cancer	0.000296	0.0009	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000284	0.000862	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000283	0.000859	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000276	0.000838	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—MAPK1—ovarian cancer	0.000271	0.000823	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000271	0.000823	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000266	0.000808	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000265	0.000806	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000265	0.000805	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000264	0.000803	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—MAPK1—ovarian cancer	0.000263	0.000799	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.00026	0.000789	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—MAPK1—ovarian cancer	0.000259	0.000785	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—HRAS—ovarian cancer	0.000258	0.000785	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—HRAS—ovarian cancer	0.000255	0.000773	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—MAPK1—ovarian cancer	0.000254	0.000772	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—MAPK1—ovarian cancer	0.000252	0.000766	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—MAPK1—ovarian cancer	0.000248	0.000753	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—HRAS—ovarian cancer	0.000241	0.000732	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—HRAS—ovarian cancer	0.000238	0.000722	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000227	0.000689	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—HRAS—ovarian cancer	0.000218	0.000661	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—MAPK1—ovarian cancer	0.000217	0.000658	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000216	0.000657	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—HRAS—ovarian cancer	0.000211	0.000642	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—HRAS—ovarian cancer	0.000208	0.00063	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—HRAS—ovarian cancer	0.000204	0.000619	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—HRAS—ovarian cancer	0.000203	0.000615	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYTB—ovarian cancer	0.000202	0.000612	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—HRAS—ovarian cancer	0.000199	0.000604	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000197	0.000598	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—NME2—ovarian cancer	0.000188	0.000571	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PPP1CC—ovarian cancer	0.000176	0.000535	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—BRIP1—ovarian cancer	0.000176	0.000535	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—HRAS—ovarian cancer	0.000174	0.000528	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000128	0.00039	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYTB—ovarian cancer	0.000121	0.000368	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—YAP1—ovarian cancer	0.000118	0.000359	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000117	0.000355	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PPP1CC—ovarian cancer	0.000106	0.000322	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—BRIP1—ovarian cancer	0.000106	0.000322	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000103	0.000312	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—FASN—ovarian cancer	9.63e-05	0.000293	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SLC5A5—ovarian cancer	9.48e-05	0.000288	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SLC2A1—ovarian cancer	9.15e-05	0.000278	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.96e-05	0.000272	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP1B1—ovarian cancer	8.77e-05	0.000266	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	7.78e-05	0.000236	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.74e-05	0.000235	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ABCB1—ovarian cancer	7.23e-05	0.000219	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—YAP1—ovarian cancer	7.11e-05	0.000216	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—TYMS—ovarian cancer	7.1e-05	0.000215	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—FASN—ovarian cancer	5.79e-05	0.000176	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CAV1—ovarian cancer	5.72e-05	0.000174	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SLC5A5—ovarian cancer	5.7e-05	0.000173	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SLC2A1—ovarian cancer	5.5e-05	0.000167	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.46e-05	0.000166	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP1B1—ovarian cancer	5.28e-05	0.00016	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PIK3CG—ovarian cancer	5.21e-05	0.000158	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	4.68e-05	0.000142	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PIK3CD—ovarian cancer	4.58e-05	0.000139	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ABCB1—ovarian cancer	4.35e-05	0.000132	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—TYMS—ovarian cancer	4.27e-05	0.00013	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PIK3CB—ovarian cancer	3.99e-05	0.000121	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PTEN—ovarian cancer	3.45e-05	0.000105	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CAV1—ovarian cancer	3.44e-05	0.000104	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.13e-05	9.51e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.75e-05	8.36e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PIK3CA—ovarian cancer	2.43e-05	7.39e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.4e-05	7.29e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PTEN—ovarian cancer	2.07e-05	6.3e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—AKT1—ovarian cancer	1.99e-05	6.03e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.46e-05	4.44e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—AKT1—ovarian cancer	1.2e-05	3.63e-05	CbGpPWpGaD
